Brief: Athenex Provides Update From FDA Type A Meeting Regarding Oral Paclitaxel Plus Encequidar For The Treatment Of Metastatic Breast Cancer
06/07/2021 12:17
July 6 (Reuters) - Athenex Inc ATNX.O :
* ATHENEX PROVIDES UPDATE FROM FDA TYPE A MEETING REGARDING
ORAL
PACLITAXEL PLUS ENCEQUIDAR FOR THE TREATMENT OF METASTATIC
BREAST CANCER
* ATHENEX INC - HELD A TYPE A MEETING WITH FDA DURING Q2 OF
2021
TO DISCUSS DEFICIENCIES RAISED IN CRL RECEIVED IN FEBRUARY
* ATHENEX INC - EVALUATING OPTIMAL DESIGN FOR A NEW CLINICAL
STUDY
WHICH IT INTENDS TO PRESENT TO FDA IN Q4 OF 2021
Source text for Eikon: ID:nGNX4yHqF2
Further company coverage: ATNX.O
((Reuters.Briefs@thomsonreuters.com;))